Erik Nordling

Principal Scientist, Biomedical Science & Portfolio Innovation
Swedish Orphan Biovitrum AB
Nina E. Weisser
Dr Erik Nordling is a Principal Scientist working in the Biomedical Science and Portfolio Innovation department at Sobi. Dr Nordling has been involved in the establishment of the Elvera Technology at Sobi and is responsible for platform technologies relating protein design. Dr. Nordling has a M.Sc. in Chemistry from the Mid Sweden University and holds a PhD in Medical Biochemistry from Karolinska Institutet, Sweden.


No data was found